Skip to main content
Premium Trial:

Request an Annual Quote

BD Posts Q3 Revenue Increase of 2 Percent

NEW YORK (GenomeWeb News) – Becton Dickinson today reported that its third-quarter revenues increased nearly 2 percent, but were up 5 percent on a currency-neutral basis.

The Franklin Lakes, NJ-based medical devices, diagnostics, and research products firm generated total revenues of $1.98 billion for the quarter ended June 30, compared to $1.95 billion for the third quarter of 2011. It missed analysts' consensus estimate of $2.02 billion.

Sales for its BD Diagnostics segment increased 2 percent to $642.3 million from $631.4 million, but were up 4 percent on a currency-neutral basis. Its BD Biosciences segment posted sales of $268.2 million, down 3 percent from $275.7 million and flat year over year on a currency-neutral basis. The BD Medical segment reported sales of $1.07 billion, up 2 percent from $1.04 billion and up 6 percent on a currency-neutral basis.

BD posted net income of $326.9 million, or $1.59 per share, compared to net income of $343.1 million, or $1.53 per share, for Q3 2011. Excluding income from discontinued operations — the BD Biosciences – Labware unit the firm is in the process of selling to Corning for $730 million — its EPS for the quarter was $1.52. Analysts, on average, had expected $1.53.

BD's R&D spending increased 1 percent to $115 million from $114 million, and its selling and administrative costs were up a fraction of a percent at $469.1 million from $468 million.

The firm said that it full-year revenues are expected to be up 1 percent versus its previously disclosed guidance of 1 to 2 percent. It expects to report EPS from continuing operations of $5.33 to $5.38.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.